APHEC 2021
PHA Europe has run an annual conference for many years in a row. We usually meet in a hotel by the beach just south of Barcelona. We call it APHEC (Annual PH European Conference). The participants are leaders of the European national associations.Mariposa Journal – 2021 winter N.27
Dear Friends, Colleagues and Supporters, It is with mixed feelings that I started writing this editorial. We had hoped that thanks to various precautionary measures we would be in the position to organize our long-awaited Annual PH European Conference again in person this fall. Unfortunately,3rd Baltic Pulmonary Hypertension and Circulation Conference
Estonia, Tallinn – 01.10.2021 09:30 – 01.10.2021 20:00 [hybrid event] Years of dedication and collaboration within the pulmonary hypertension (PH) community have vastly increased our knowledge of this progressive disease. This has led to the intelligent use of targeted therapies and evidence-based management strategies, whichERS Statement on CTEPH is published!
The ERS Statement on Chronic Thromboembolic Pulmonary Hypertension (CTEPH) has now been published online in the European Respiratory Journal (ERJ) as an early view.World Pulmonary Hypertension Day 2019
The first WPHD was organized in Madrid on 5 of May, 2012 and we are happy that since then we have managed to organize our “breathtaking” series of events in each year under the theme of “Get Breathless for PH”.World Pulmonary Hypertension Day 2018
On the 5th May of 2018, we showed the international community what it is like to live with PH, continuing with our successful “Get breathless for PH” campaign. Healthy people were encouraged to take part in high-energy sports and activities to get breathless, driving awarenessPHA Europe 2014 September
New developments in treatments and treatment strategies for pulmonary hypertension The two largest congresses in the fields of cardiology and respiratory medicine have taken place recently and it was very encouraging to see that a number of sessions were dedicated to pulmonary arterial hypertension andDrug Information
Three new drugs for pulmonary hypertension have been approved by the US and/or EU regulatory authorities in the course of the last year: